小方制药
(603207)
| 流通市值：13.66亿 | | | 总市值：40.48亿 |
| 流通股本：5460.29万 | | | 总股本：1.62亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 281,930,889.08 | 145,694,452.27 | 525,280,851.39 | 397,218,590.16 |
| 营业总成本 | 159,156,289.08 | 80,034,518.55 | 283,033,965.67 | 198,287,211.92 |
| 其他经营收益 | | | | |
| 营业利润 | 123,583,674.49 | 65,587,371.39 | 241,519,793.7 | 198,450,191.52 |
| 利润总额 | 123,463,674.57 | 65,462,789.19 | 241,227,209.98 | 198,317,251.27 |
| 净利润 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 | 169,893,968.8 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 105,550,017.8 | 56,006,923.51 | 207,489,677.18 | 169,893,968.8 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 905,205,501.12 | 882,917,988.24 | 859,857,709.31 | 931,141,809.97 |
| 非流动资产: | | | | |
| 非流动资产合计 | 401,449,031.62 | 378,488,933.63 | 379,613,739.86 | 376,487,933.19 |
| 资产总计 | 1,306,654,532.74 | 1,261,406,921.87 | 1,239,471,449.17 | 1,307,629,743.16 |
| 流动负债: | | | | |
| 流动负债合计 | 163,180,690.09 | 110,787,007.23 | 146,340,087.77 | 253,478,628.08 |
| 非流动负债: | | | | |
| 非流动负债合计 | 150,298.27 | 89,477.69 | 371,360.38 | 55,714.2 |
| 负债合计 | 163,330,988.36 | 110,876,484.92 | 146,711,448.15 | 253,534,342.28 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,143,323,544.38 | 1,150,530,436.95 | 1,092,760,001.02 | 1,054,095,400.88 |
| 股东权益合计 | 1,143,323,544.38 | 1,150,530,436.95 | 1,092,760,001.02 | 1,054,095,400.88 |
| 负债和股东权益合计 | 1,306,654,532.74 | 1,261,406,921.87 | 1,239,471,449.17 | 1,307,629,743.16 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 314,794,135.84 | 154,822,126.7 | 566,040,805.13 | 419,255,318.75 |
| 经营活动现金流出小计 | 217,058,859.01 | 109,490,900.1 | 405,244,155.65 | 285,318,600.95 |
| 经营活动产生的现金流量净额 | 97,735,276.83 | 45,331,226.6 | 160,796,649.48 | 133,936,717.8 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 149,281,500 | 4,730,208.33 | 927,249,283.35 | 556,770,936.13 |
| 投资活动现金流出小计 | 385,764,231.19 | 359,097,176.78 | 621,240,215.64 | 469,140,746.75 |
| 投资活动产生的现金流量净额 | -236,482,731.19 | -354,366,968.45 | 306,009,067.71 | 87,630,189.38 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 9,109,533.75 | 9,674,978.61 | 9,501,775.57 | 10,158,745.73 |
| 筹资活动现金流出小计 | 20,016,031.12 | 40,500 | 358,967,747.4 | 246,009,950.5 |
| 筹资活动产生的现金流量净额 | -10,906,497.37 | 9,634,478.61 | -349,465,971.83 | -235,851,204.77 |
| 汇率变动对现金及现金等价物的影响 | - | - | - | - |
| 现金及现金等价物净增加额 | -149,653,951.73 | -299,401,263.24 | 117,339,745.36 | -14,284,297.59 |
| 期末现金及现金等价物余额 | 394,535,644.62 | 244,788,333.11 | 544,189,596.35 | 412,565,553.4 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -149,653,951.73 | - | 117,339,745.36 | - |